Abstract
The aim of the present study was to assess the relationship between white blood cell (WBC) or red blood cell (RBC) counts, and metabolic syndrome (MS). We analyzed 5,178 subjects ≥20 yr of age, who participated in the 2005 Korean National Health and Nutrition Examination Survey. Each multivariate adjusted mean of WBC and RBC was significantly higher in subjects with MS components than the control group, respectively, with the exception for men with hyperglycemia and women with lower values of high-density lipoprotein (HDL) cholesterol. WBC and RBC counts were correlated with MS components. In multivariate logistic regression analysis, the highest quartile of WBC or RBC counts were presented with 1.5- or 2.5-fold increases in the risk of MS, respectively, compared to the lowest quartile groups. These findings demonstrated that increased WBC or RBC counts within the reference range could associated with various MS components and the risk of MS in the Korean population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Grundy, S. M. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.Am. J. Cardiol. 83, 25F-29F (1999).
Malik, S.et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all in United States adults.Circulation 110, 1245–1250 (2004).
Important death cause in Korea; 2003 Korea National Statistical Office, Seoul (2005).
Park, H. S.et al. Prevalenec and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998–2001.Diabetes Obes. Metab. 9, 50–58 (2007).
Isomaa, B.et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome.Diabetes Care 24, 683–689 (2001).
Girman, C. J.et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS /TexCAPS).Am. J. Cardiol. 93, 136–141 (2004).
Koenig, W.et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular disease) Augsburg Cohort Study, 1984 to 1992.Circulation 99, 237–242 (1999).
Pearson, T. A.et al. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association.Circulation 107, 499–511 (2003).
Barbieri, M.et al. New aspescts of the insulin resistance stndrome: impact on hematological parameters.Diabetologia 44, 1232–1237 (2001).
Lowe, G.et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study.Thromb. Haemost. 84, 553–558 (2000).
Shimakawa, T. & Bild, D. E. Relationship between hemoglobin and cardiovascular risk factors in young adults.J. Clin. Epidemiol. 46, 1257–1266 (1993).
Shim, W. S.et al. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients.Diabetes Res. Clin. Pract. 73, 284–291 (2006).
Kim, J. A.et al. Association of metabolic syndrome with white blood cell subtype and red blood cells.Endocr. J. 53, 133–139 (2006).
Lohsoonthorn, V., Dhanamun, B. & Williams, M. A. Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations.Am. J. Hypertens. 19, 339–345 (2006).
Nakanishi, N.et al. Associations between white blood cell count and features of the metabolic syndrome in Japanese male office workers.Ind. Health 40, 273–277 (2002).
Fernadez-Real, J. M. & Ricart, W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness.Diabetologia 42, 1367–1374 (1999).
Mohamed-Ali, V.et al. Subcutaneous adipose tissue release interlukine-6, but not tumor necrosis factor-α, in vitro.J. Clin. Endocrinol. Metab. 82, 4196–4200 (1997).
Fernadez-Real, J. M.et al. Circulationg interlukine 6 levels blood pressure, and insulin sensitivity in apparently healthy men and women.J. Clin. Endocrinol. Metab. 86, 1154–1159 (2001).
Sims, E. inHumoral factors 1-373 (IRL Press, Oxford, 1993).
Henrichot, E.et al. Production of chemokines by perivascular adipose tissue. A role in the pathogenesis of atherosclerosis?Arterioscler. Thromb. Vasc. Biol. 25, 2594–2599 (2005).
Barbieri, M.et al. New aspescts of the insulin resistance stndrome: impact on hematological parameters.Diabetologia 44, 1232–1237 (2001).
Fernadez-Real, J. M.et al. Blood letting in high ferritin type 2 diabetes: effect on insulin sensitivity and β-cell function.Diabetes 51, 1000–1004 (2002).
Brun, J. F., Aloulou, I. & Varlet-Marie, E. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity, or hyperinsulinemia?Clin. Hemorhol. Microcirc. 30, 203–209 (2004).
Wang, Y. Y.et al. Association between hematological parameters and metabolic syndrome components in a Chinese population.J. Diabet. Compli. 18, 322–327 (2004).
WHO Western Pacific Region, International Association for the Study of Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and its Treatment, Health Communications Australia, Sydney, Australia (2000).
Genuth, S.et al. The expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus.Diabetes Care 26, 3160–3167 (2003).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kim, JK., Lee, YJ., Lee, JW. et al. Association between white blood cell and red blood cell counts within reference range and metabolic syndrome in Korean men and women. Toxicol. Environ. Health. Sci. 2, 238–244 (2010). https://doi.org/10.1007/BF03217489
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03217489